Indeed, higher osteocalcin levels were reported to be associated with greater insulin sensitivity, lower BMI and lower systolic blood pressure [66,67], while T2M and obesity were associated with lower osteocalcin concentrations [66,68]. Here, BGLAP is linked to obesity due to melanocortin 4 receptor deficiency.